Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: Potential immunoregulatory role

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 165-172

  Pelidou, Sigliti Henrietta ^a   Zou, Li Ping ^a   Deretzi, Georgia ^a   Oniding, Cecilia ^a   Mix, Eilhard ^b   Zhu, Jie ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chronic experimental autoimmune neuritis; Nasal administration; Recombinant mouse interleukin 17

Indexed keywords

INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATING DISEASE; IMMUNOREGULATION; INFLAMMATORY CELL; LYMPH NODE; MALE; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SCIATIC NERVE; T LYMPHOCYTE;

EID: 0034106554     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7357     Document Type: Article

References (36)

1. Alastair J., Bradley J. A. Interleukin-12 induces interferon-γ-dependent switching of IgG antibody subclass. Eur. J. Immunol. 26:1996;1217-1221.
2. Attur M. G., Patel R. N., Abramson S. B., Amin A. R. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum. 40:1997;1050-1053.
3. Bakhiet M., Diab A., Mustafa M., Zhu J., Lindqvist L., Link H. A novel mechanism for regulation of cytokine responses in bacterial infections. Infect. Immun. 65:1997;3300-3303.
4. Dick A. D., Cheng Y. F., Liversidge J., Forrester J. V. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology. 82:1994;625-631.
5. Fearon E. R., Pardoll D. M., Itala T., Golumbek P., Levitsky H. I., Simons I. W., Karasuyama H., Vogelstein B., Frost P. Interleukin 2 production by tumor cells bypasses T helper function in the generation of an anti-tumor response. Cell. 60:1990;397-399.
6. Finklman F. D., Holmes J., Katona I. M., Urban J. F. Jr., Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of immunoglobulin isotype selection. Annu. Rev. Immunol. 8:1990;303-333.
7. Fossiez F., Banchereau J., Murray R., Kooten C. V., Garrone P., Lebecque S. Interleukin-17. Int. Rev. Immunol. 16:1998;541-551.
8. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J. J., Garrone P., Garcia E., Saeland S., Blanchard D., Gaillard C., Dasmahapatra B., Rovier E., Golstein P., Banchereau J., Lebecque S. T-cell IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:1996;2593-2603.
9. Gautam S., Tebo J. M., Hamilton T. A. IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages. J. Immunol. 148:1992;1725-1730.
10. Hahn A. F. Experimental allergic neuritis as a model for the immune-mediated demyelinating neuropathies. Rev. Neurol. 152:1996;328-332.
11. Hahn A. F., Feasby T. E., Steele A., Lovgren D. S., Berry J. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depends on the myelin dosage. Lab. Invest. 59:1998;115-125.
12. Hartung H. P. Pathogenesis of inflammatory demyelination: Implications for therapy. Curr. Opin. Neurol. 8:1995;191-199.
13. Harvey G. K., Pollard J. D., Schindhelm K., Antony J. Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit. J. Neurol. Sci. 81:1987;215-225.
14. Illum L. The nasal delivery of peptides and proteins. Trends Biotechnol. 9:1991;284-289.
15. Jovanovic D. V., Di Battista J. A., Martel-Pelletier J., Jolicoeur F. C., He Y., Zhang M., Mineau F., Pelletier J. P. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1beta and TNF-alpha, by human macrophages. J. Immunol. 160:1998;3513-3521.
16. Jung S., Huitinga I., Schmidt B., Zielasek J., Dijkstra C. D., Toyka K. V., Hartung H. P. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis. J. Neurol. Sci. 119:1993;195-202.
17. - T cells. J. Interferon Cytokine Res. 16:1996;611-617.
18. Lassmann H., Fierz W., Neuchrist C., Meyermann R. Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain. 114:1991;429-442.
19. McCombe P. A., van der Kreek S. A., Pender M. P. The effects of cyclosporine A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporine A. J. Neuroimmunol. 28:1990;131-140.
20. Metzler B., Wraith D. C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Inhibition of MHC binding affinity. Int. Immunol. 5:1993;1159-1165.
21. Olee T., Powell J. M., Brostoff S. W. A T cell epitope for experimental allergic neuritis. J. Neuroimmunol. 19:1988;167-173.
22. + T cells. J. Exp. Med. 185:1997;461-469.
23. Romagnani S. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 4:1996;470-473.
24. Rouvier E., Luciani M. F., Mattei M. G., Denizot F., Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150:1993;5445-5456.
25. Said G., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
26. Stoll G., Jung S., Jander S., van der Meide P., Hartung H. P. Tumor necrosis factor-α in immune mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45:1993;175-182.
27. Waldo F. B., van den Wall Bake A. W., Mestecky J., Husby S. Suppression of the immune response by nasal immunisation. Clin. Immunol. Immunopathol. 72:1994;30-34.
28. Van Kooten C., Boonstra J. G., Paape M. E., Fossiez F., Banchereau J., Lebecque S., Bruijn J. A., de Fijter J. W., van Es L. A., Daha M. R. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Nephrol. 9:1998;1526-1534.
29. Wu H. Y., Russel M. W. Nasal lymphoid tissue intranasal immunisation and compartmentalisation of the common mucosal immune system. Immunol. Res. 16:1997;187-201.
30. Xiao B. G., Bai X. F., Zhang G. X., Link H. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats. J. Neuroimmunol. 84:1998;230-237.
31. Yao Z., Spriggs M. K., Derry J. M., Strockbine L., Park L. S., VandenBos T., Zappone J. D., Painter S. L., Armitage R. J. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine. 9:1997;794-800.
32. Yao Z., Painter S. L., Fanslow W. C., Ulrich D., Macduff B. M., Spriggs M. K., Armitage R. J. Human IL-17: A novel cytokine derived from T cells. J. Immunol. 155:1995;5483-5486.
33. Yao Z., Fanslow W. C., Seldin M. F., Rousseau A. M., Painter S. L., Comeau M. R., Cohen J. I., Spriggs M. K. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 3:1995;811-821.
34. Zhu J., Link H., Mix E., Olsson T., Huang W. X. Th1-like cell response to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol. Scand. 90:1994;19-25.
35. Zhu J., Bai X. F., Mix E., Link H. Cytokine dichotomy in the peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and cytolysin. Clin. Immunol. Immunopathol. 84:1997;85-94.
36. Zhu J., Mix E., Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome. J. Neuroimmunol. 84:1998;40-52.